Navigation Links
ThermaGenix, Inc. Announces Start-up and Exclusive Licenses from Brandeis University
Date:3/18/2017

ThermaGenix, Inc., a new life sciences company, announces that it has exclusively licensed certain technologies from Brandeis University that significantly enhance detection and analysis of nucleic acids, both DNA and RNA, via the Polymerase Chain Reaction (PCR). These platform technologies are applicable to diagnostics of human cancers and infectious diseases, as well as genomic analysis of virtually all forms of life.

Starting in May 2017, ThermaGenix, Inc. will sell Therma-StopTM and Therma-GoTM, its lead products that enhance the sensitivity and accuracy of conventional PCR reactions. ThermaGenix will also utilize additional methods and reagents it has licensed from the University to construct highly informative molecular diagnostics tests for cancer-related mutations in DNA recovered from blood plasma (liquid biopsies), as well as molecular assays for species identification.

“ThermaGenix is thrilled to bring these products and processes to the life science research and diagnostics markets,” said Peter Coassin, President of ThermaGenix. “The products and processes reflect the impressive and measurable technology that has been developed, published and patented by the team at Brandeis University. These new products – as well as other technologies ThermaGenix has licensed and will commercialize – will make crucial medical procedures faster, more effective and more affordable.”

For more than 20 years, Professor Lawrence Wangh and colleagues have investigated and improved virtually every aspect of PCR and RT-PCR amplification of DNA and RNA. Their additive reagents eliminate all forms of mis-priming before, during and after PCR and RT-PCR amplification and thereby increase assay quality, quantitative accuracy, sensitivity and multiplexing capabilities.

In 2016, Wangh joined forces with Coassin, a life science product veteran with more than 30 patented products and processes. Together, the Thermagenix team invents, commercializes and supports innovative products for life science research.

“Over the last twenty years my laboratory colleagues and I at Brandeis have had the good fortune to explore and solve PCR errors which are frequently unknown or swept under the rug. The result is optimized reagents and methods that eliminate these problems and make it possible to design more sensitive, more robust, and more informative assays than ever before. In collaboration with colleagues around the world we have built and are building a variety of assays using these technologies. With optimized reagents and methods, the public benefits from this leading-edge technology,” said Professor Wangh.

About ThermaGenix, Inc.:
ThermaGenix, Inc. (http://www.thermagenix.com) is a leading innovator and provider of PCR reagents and PCR assays for use in the most widely adopted research processes involving DNA amplification strategies. ThermaGenix’s innovative PCR additives improve polymerase specificity and fidelity, enabling quantitatively accurate multiplexed end-point analysis of amplified products in closed-tube reactions, as well as downstream utilization of reaction products via Next Generation Sequencing (NGS) and Gibson assembly. The ThermaGenix team of core scientists have 20+ years of inventing, commercializing and supporting innovative products for life science research. ThermaGenix was founded in 2014 by Professor Lawrence Wangh of Brandeis University, and has obtained very broad rights to the ThermaStop™, ThermaGo™, and ThermaMark™, as well as LATE-PCR and Lights-On/Lights-Off Probes from Brandies University.

About Brandeis University:
Brandeis University is a highly competitive private research university with a focus on undergraduate education. Founded in 1948 by the American Jewish community and named for Supreme Court Justice Louis D. Brandeis, Brandeis embraces the values of academic excellence, critical thinking, openness to all, and making the world a better place. Brandeis is a member of the Association of American Universities (AAU), which represents the 62 leading research universities in the United States and Canada. Located just west of Boston in Waltham, Massachusetts, Brandeis’ distinguished faculty are dedicated to the education and support of 3,600 undergraduates and more than 2,000 graduate students.

####

Read the full story at http://www.prweb.com/releases/2017/03/prweb14159186.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. ComplianceOnline Announces Seminar on Pharmacovigilance Audit Strategy Planning
2. NW BIO Announces Registered Direct Offering Of $7.5 Million
3. BioAmber Announces Year End Operational and Financial Results for 2016
4. FundRx Announces Investment in NeuroOne Inc.
5. PMG Research Announces Clinical Trial Community with Smart Patients
6. Cellecta, Inc. Announces Upcoming Presentations at the American Association for Cancer Research 2017 Annual Meeting
7. Eurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis Service
8. OncoSec Announces First Technology Access Program Agreement with Inhibrx
9. Dove Press Announces Sponsorship of Nanomedicine Academy of Minority Serving Institutions at Northeastern University
10. Northwest Kidney Centers Announces Intention to Grant $15 Million to Jumpstart UW Medicines Center for Dialysis Innovation
11. Integrated Service Solutions, Inc. Announces Expanded Scope of Accreditation by A2LA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... ... 2017 , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on ... DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
Breaking Biology Technology:
(Date:6/23/2017)... and ITHACA, N.Y. , June 23, ... University, a leader in dairy research, today announced a ... to help reduce the chances that the global milk ... of this dairy project, Cornell University has become the ... the Food Supply Chain, a food safety initiative that ...
(Date:5/23/2017)... -- Hunova, the first robotic gym for the rehabilitation and functional motor sense ... Genoa, Italy . The first 30 robots will be available ... USA . The technology was developed and patented at the IIT ... Movendo Technology thanks to a 10 million euro investment from entrepreneur Sergio ... ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
Breaking Biology News(10 mins):